A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

NCT06903702 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine (AZA)
DRUG: Venetoclax
PROCEDURE: Allogeneic hematopoietic stem cell transplantation

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]